1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Hypersomnia Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Provigil
        1.2.3 Xyrem
        1.2.4 Others
    1.3 Market by Application
        1.3.1 Global Hypersomnia Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital Pharmacies
        1.3.3 Retail Pharmacies
        1.3.4 Online Pharmacies
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Hypersomnia Drug Market Perspective (2017-2028)
    2.2 Hypersomnia Drug Growth Trends by Region
        2.2.1 Hypersomnia Drug Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Hypersomnia Drug Historic Market Size by Region (2017-2022)
        2.2.3 Hypersomnia Drug Forecasted Market Size by Region (2023-2028)
    2.3 Hypersomnia Drug Market Dynamics
        2.3.1 Hypersomnia Drug Industry Trends
        2.3.2 Hypersomnia Drug Market Drivers
        2.3.3 Hypersomnia Drug Market Challenges
        2.3.4 Hypersomnia Drug Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Hypersomnia Drug Players by Revenue
        3.1.1 Global Top Hypersomnia Drug Players by Revenue (2017-2022)
        3.1.2 Global Hypersomnia Drug Revenue Market Share by Players (2017-2022)
    3.2 Global Hypersomnia Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Hypersomnia Drug Revenue
    3.4 Global Hypersomnia Drug Market Concentration Ratio
        3.4.1 Global Hypersomnia Drug Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Hypersomnia Drug Revenue in 2021
    3.5 Hypersomnia Drug Key Players Head office and Area Served
    3.6 Key Players Hypersomnia Drug Product Solution and Service
    3.7 Date of Enter into Hypersomnia Drug Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Hypersomnia Drug Breakdown Data by Type
    4.1 Global Hypersomnia Drug Historic Market Size by Type (2017-2022)
    4.2 Global Hypersomnia Drug Forecasted Market Size by Type (2023-2028)
5 Hypersomnia Drug Breakdown Data by Application
    5.1 Global Hypersomnia Drug Historic Market Size by Application (2017-2022)
    5.2 Global Hypersomnia Drug Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Hypersomnia Drug Market Size (2017-2028)
    6.2 North America Hypersomnia Drug Market Size by Type
        6.2.1 North America Hypersomnia Drug Market Size by Type (2017-2022)
        6.2.2 North America Hypersomnia Drug Market Size by Type (2023-2028)
        6.2.3 North America Hypersomnia Drug Market Share by Type (2017-2028)
    6.3 North America Hypersomnia Drug Market Size by Application
        6.3.1 North America Hypersomnia Drug Market Size by Application (2017-2022)
        6.3.2 North America Hypersomnia Drug Market Size by Application (2023-2028)
        6.3.3 North America Hypersomnia Drug Market Share by Application (2017-2028)
    6.4 North America Hypersomnia Drug Market Size by Country
        6.4.1 North America Hypersomnia Drug Market Size by Country (2017-2022)
        6.4.2 North America Hypersomnia Drug Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Hypersomnia Drug Market Size (2017-2028)
    7.2 Europe Hypersomnia Drug Market Size by Type
        7.2.1 Europe Hypersomnia Drug Market Size by Type (2017-2022)
        7.2.2 Europe Hypersomnia Drug Market Size by Type (2023-2028)
        7.2.3 Europe Hypersomnia Drug Market Share by Type (2017-2028)
    7.3 Europe Hypersomnia Drug Market Size by Application
        7.3.1 Europe Hypersomnia Drug Market Size by Application (2017-2022)
        7.3.2 Europe Hypersomnia Drug Market Size by Application (2023-2028)
        7.3.3 Europe Hypersomnia Drug Market Share by Application (2017-2028)
    7.4 Europe Hypersomnia Drug Market Size by Country
        7.4.1 Europe Hypersomnia Drug Market Size by Country (2017-2022)
        7.4.2 Europe Hypersomnia Drug Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Hypersomnia Drug Market Size (2017-2028)
    8.2 Asia-Pacific Hypersomnia Drug Market Size by Type
        8.2.1 Asia-Pacific Hypersomnia Drug Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Hypersomnia Drug Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Hypersomnia Drug Market Share by Type (2017-2028)
    8.3 Asia-Pacific Hypersomnia Drug Market Size by Application
        8.3.1 Asia-Pacific Hypersomnia Drug Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Hypersomnia Drug Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Hypersomnia Drug Market Share by Application (2017-2028)
    8.4 Asia-Pacific Hypersomnia Drug Market Size by Region
        8.4.1 Asia-Pacific Hypersomnia Drug Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Hypersomnia Drug Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Hypersomnia Drug Market Size (2017-2028)
    9.2 Latin America Hypersomnia Drug Market Size by Type
        9.2.1 Latin America Hypersomnia Drug Market Size by Type (2017-2022)
        9.2.2 Latin America Hypersomnia Drug Market Size by Type (2023-2028)
        9.2.3 Latin America Hypersomnia Drug Market Share by Type (2017-2028)
    9.3 Latin America Hypersomnia Drug Market Size by Application
        9.3.1 Latin America Hypersomnia Drug Market Size by Application (2017-2022)
        9.3.2 Latin America Hypersomnia Drug Market Size by Application (2023-2028)
        9.3.3 Latin America Hypersomnia Drug Market Share by Application (2017-2028)
    9.4 Latin America Hypersomnia Drug Market Size by Country
        9.4.1 Latin America Hypersomnia Drug Market Size by Country (2017-2022)
        9.4.2 Latin America Hypersomnia Drug Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Hypersomnia Drug Market Size (2017-2028)
    10.2 Middle East & Africa Hypersomnia Drug Market Size by Type
        10.2.1 Middle East & Africa Hypersomnia Drug Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Hypersomnia Drug Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Hypersomnia Drug Market Share by Type (2017-2028)
    10.3 Middle East & Africa Hypersomnia Drug Market Size by Application
        10.3.1 Middle East & Africa Hypersomnia Drug Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Hypersomnia Drug Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Hypersomnia Drug Market Share by Application (2017-2028)
    10.4 Middle East & Africa Hypersomnia Drug Market Size by Country
        10.4.1 Middle East & Africa Hypersomnia Drug Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Hypersomnia Drug Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Teva
        11.1.1 Teva Company Details
        11.1.2 Teva Business Overview
        11.1.3 Teva Hypersomnia Drug Introduction
        11.1.4 Teva Revenue in Hypersomnia Drug Business (2017-2022)
        11.1.5 Teva Recent Developments
    11.2 Jazz Pharmaceuticals
        11.2.1 Jazz Pharmaceuticals Company Details
        11.2.2 Jazz Pharmaceuticals Business Overview
        11.2.3 Jazz Pharmaceuticals Hypersomnia Drug Introduction
        11.2.4 Jazz Pharmaceuticals Revenue in Hypersomnia Drug Business (2017-2022)
        11.2.5 Jazz Pharmaceuticals Recent Developments
    11.3 BIOPROJET
        11.3.1 BIOPROJET Company Details
        11.3.2 BIOPROJET Business Overview
        11.3.3 BIOPROJET Hypersomnia Drug Introduction
        11.3.4 BIOPROJET Revenue in Hypersomnia Drug Business (2017-2022)
        11.3.5 BIOPROJET Recent Developments
    11.4 AVADEL PHARMACEUTICALS
        11.4.1 AVADEL PHARMACEUTICALS Company Details
        11.4.2 AVADEL PHARMACEUTICALS Business Overview
        11.4.3 AVADEL PHARMACEUTICALS Hypersomnia Drug Introduction
        11.4.4 AVADEL PHARMACEUTICALS Revenue in Hypersomnia Drug Business (2017-2022)
        11.4.5 AVADEL PHARMACEUTICALS Recent Developments
    11.5 GlaxoSmithKline
        11.5.1 GlaxoSmithKline Company Details
        11.5.2 GlaxoSmithKline Business Overview
        11.5.3 GlaxoSmithKline Hypersomnia Drug Introduction
        11.5.4 GlaxoSmithKline Revenue in Hypersomnia Drug Business (2017-2022)
        11.5.5 GlaxoSmithKline Recent Developments
    11.6 Pfizer
        11.6.1 Pfizer Company Details
        11.6.2 Pfizer Business Overview
        11.6.3 Pfizer Hypersomnia Drug Introduction
        11.6.4 Pfizer Revenue in Hypersomnia Drug Business (2017-2022)
        11.6.5 Pfizer Recent Developments
    11.7 Theranexus
        11.7.1 Theranexus Company Details
        11.7.2 Theranexus Business Overview
        11.7.3 Theranexus Hypersomnia Drug Introduction
        11.7.4 Theranexus Revenue in Hypersomnia Drug Business (2017-2022)
        11.7.5 Theranexus Recent Developments
    11.8 Fisher & Paykel Healthcare
        11.8.1 Fisher & Paykel Healthcare Company Details
        11.8.2 Fisher & Paykel Healthcare Business Overview
        11.8.3 Fisher & Paykel Healthcare Hypersomnia Drug Introduction
        11.8.4 Fisher & Paykel Healthcare Revenue in Hypersomnia Drug Business (2017-2022)
        11.8.5 Fisher & Paykel Healthcare Recent Developments
    11.9 Drive Medical
        11.9.1 Drive Medical Company Details
        11.9.2 Drive Medical Business Overview
        11.9.3 Drive Medical Hypersomnia Drug Introduction
        11.9.4 Drive Medical Revenue in Hypersomnia Drug Business (2017-2022)
        11.9.5 Drive Medical Recent Developments
    11.10 Merck
        11.10.1 Merck Company Details
        11.10.2 Merck Business Overview
        11.10.3 Merck Hypersomnia Drug Introduction
        11.10.4 Merck Revenue in Hypersomnia Drug Business (2017-2022)
        11.10.5 Merck Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Hypersomnia Drug Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Provigil
    Table 3. Key Players of Xyrem
    Table 4. Key Players of Others
    Table 5. Global Hypersomnia Drug Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 6. Global Hypersomnia Drug Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Hypersomnia Drug Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Hypersomnia Drug Market Share by Region (2017-2022)
    Table 9. Global Hypersomnia Drug Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Hypersomnia Drug Market Share by Region (2023-2028)
    Table 11. Hypersomnia Drug Market Trends
    Table 12. Hypersomnia Drug Market Drivers
    Table 13. Hypersomnia Drug Market Challenges
    Table 14. Hypersomnia Drug Market Restraints
    Table 15. Global Hypersomnia Drug Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Hypersomnia Drug Revenue Share by Players (2017-2022)
    Table 17. Global Top Hypersomnia Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hypersomnia Drug as of 2021)
    Table 18. Ranking of Global Top Hypersomnia Drug Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Hypersomnia Drug Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Hypersomnia Drug Product Solution and Service
    Table 22. Date of Enter into Hypersomnia Drug Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Hypersomnia Drug Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Hypersomnia Drug Revenue Market Share by Type (2017-2022)
    Table 26. Global Hypersomnia Drug Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Hypersomnia Drug Revenue Market Share by Type (2023-2028)
    Table 28. Global Hypersomnia Drug Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Hypersomnia Drug Revenue Share by Application (2017-2022)
    Table 30. Global Hypersomnia Drug Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Hypersomnia Drug Revenue Share by Application (2023-2028)
    Table 32. North America Hypersomnia Drug Market Size by Type (2017-2022) & (US$ Million)
    Table 33. North America Hypersomnia Drug Market Size by Type (2023-2028) & (US$ Million)
    Table 34. North America Hypersomnia Drug Market Size by Application (2017-2022) & (US$ Million)
    Table 35. North America Hypersomnia Drug Market Size by Application (2023-2028) & (US$ Million)
    Table 36. North America Hypersomnia Drug Market Size by Country (2017-2022) & (US$ Million)
    Table 37. North America Hypersomnia Drug Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Europe Hypersomnia Drug Market Size by Type (2017-2022) & (US$ Million)
    Table 39. Europe Hypersomnia Drug Market Size by Type (2023-2028) & (US$ Million)
    Table 40. Europe Hypersomnia Drug Market Size by Application (2017-2022) & (US$ Million)
    Table 41. Europe Hypersomnia Drug Market Size by Application (2023-2028) & (US$ Million)
    Table 42. Europe Hypersomnia Drug Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Europe Hypersomnia Drug Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Asia Pacific Hypersomnia Drug Market Size by Type (2017-2022) & (US$ Million)
    Table 45. Asia Pacific Hypersomnia Drug Market Size by Type (2023-2028) & (US$ Million)
    Table 46. Asia Pacific Hypersomnia Drug Market Size by Application (2017-2022) & (US$ Million)
    Table 47. Asia Pacific Hypersomnia Drug Market Size by Application (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Hypersomnia Drug Market Size by Region (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Hypersomnia Drug Market Size by Region (2023-2028) & (US$ Million)
    Table 50. Latin America Hypersomnia Drug Market Size by Type (2017-2022) & (US$ Million)
    Table 51. Latin America Hypersomnia Drug Market Size by Type (2023-2028) & (US$ Million)
    Table 52. Latin America Hypersomnia Drug Market Size by Application (2017-2022) & (US$ Million)
    Table 53. Latin America Hypersomnia Drug Market Size by Application (2023-2028) & (US$ Million)
    Table 54. Latin America Hypersomnia Drug Market Size by Country (2017-2022) & (US$ Million)
    Table 55. Latin America Hypersomnia Drug Market Size by Country (2023-2028) & (US$ Million)
    Table 56. Middle East and Africa Hypersomnia Drug Market Size by Type (2017-2022) & (US$ Million)
    Table 57. Middle East and Africa Hypersomnia Drug Market Size by Type (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa Hypersomnia Drug Market Size by Application (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa Hypersomnia Drug Market Size by Application (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Hypersomnia Drug Market Size by Country (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Hypersomnia Drug Market Size by Country (2023-2028) & (US$ Million)
    Table 62. Teva Company Details
    Table 63. Teva Business Overview
    Table 64. Teva Hypersomnia Drug Product
    Table 65. Teva Revenue in Hypersomnia Drug Business (2017-2022) & (US$ Million)
    Table 66. Teva Recent Developments
    Table 67. Jazz Pharmaceuticals Company Details
    Table 68. Jazz Pharmaceuticals Business Overview
    Table 69. Jazz Pharmaceuticals Hypersomnia Drug Product
    Table 70. Jazz Pharmaceuticals Revenue in Hypersomnia Drug Business (2017-2022) & (US$ Million)
    Table 71. Jazz Pharmaceuticals Recent Developments
    Table 72. BIOPROJET Company Details
    Table 73. BIOPROJET Business Overview
    Table 74. BIOPROJET Hypersomnia Drug Product
    Table 75. BIOPROJET Revenue in Hypersomnia Drug Business (2017-2022) & (US$ Million)
    Table 76. BIOPROJET Recent Developments
    Table 77. AVADEL PHARMACEUTICALS Company Details
    Table 78. AVADEL PHARMACEUTICALS Business Overview
    Table 79. AVADEL PHARMACEUTICALS Hypersomnia Drug Product
    Table 80. AVADEL PHARMACEUTICALS Revenue in Hypersomnia Drug Business (2017-2022) & (US$ Million)
    Table 81. AVADEL PHARMACEUTICALS Recent Developments
    Table 82. GlaxoSmithKline Company Details
    Table 83. GlaxoSmithKline Business Overview
    Table 84. GlaxoSmithKline Hypersomnia Drug Product
    Table 85. GlaxoSmithKline Revenue in Hypersomnia Drug Business (2017-2022) & (US$ Million)
    Table 86. GlaxoSmithKline Recent Developments
    Table 87. Pfizer Company Details
    Table 88. Pfizer Business Overview
    Table 89. Pfizer Hypersomnia Drug Product
    Table 90. Pfizer Revenue in Hypersomnia Drug Business (2017-2022) & (US$ Million)
    Table 91. Pfizer Recent Developments
    Table 92. Theranexus Company Details
    Table 93. Theranexus Business Overview
    Table 94. Theranexus Hypersomnia Drug Product
    Table 95. Theranexus Revenue in Hypersomnia Drug Business (2017-2022) & (US$ Million)
    Table 96. Theranexus Recent Developments
    Table 97. Fisher & Paykel Healthcare Company Details
    Table 98. Fisher & Paykel Healthcare Business Overview
    Table 99. Fisher & Paykel Healthcare Hypersomnia Drug Product
    Table 100. Fisher & Paykel Healthcare Revenue in Hypersomnia Drug Business (2017-2022) & (US$ Million)
    Table 101. Fisher & Paykel Healthcare Recent Developments
    Table 102. Drive Medical Company Details
    Table 103. Drive Medical Business Overview
    Table 104. Drive Medical Hypersomnia Drug Product
    Table 105. Drive Medical Revenue in Hypersomnia Drug Business (2017-2022) & (US$ Million)
    Table 106. Drive Medical Recent Developments
    Table 107. Merck Company Details
    Table 108. Merck Business Overview
    Table 109. Merck Hypersomnia Drug Product
    Table 110. Merck Revenue in Hypersomnia Drug Business (2017-2022) & (US$ Million)
    Table 111. Merck Recent Developments
    Table 112. Research Programs/Design for This Report
    Table 113. Key Data Information from Secondary Sources
    Table 114. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Hypersomnia Drug Market Share by Type: 2021 VS 2028
    Figure 2. Provigil Features
    Figure 3. Xyrem Features
    Figure 4. Others Features
    Figure 5. Global Hypersomnia Drug Market Share by Application: 2021 VS 2028
    Figure 6. Hospital Pharmacies Case Studies
    Figure 7. Retail Pharmacies Case Studies
    Figure 8. Online Pharmacies Case Studies
    Figure 9. Hypersomnia Drug Report Years Considered
    Figure 10. Global Hypersomnia Drug Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global Hypersomnia Drug Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Hypersomnia Drug Market Share by Region: 2021 VS 2028
    Figure 13. Global Hypersomnia Drug Market Share by Players in 2021
    Figure 14. Global Top Hypersomnia Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hypersomnia Drug as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by Hypersomnia Drug Revenue in 2021
    Figure 16. North America Hypersomnia Drug Market Size YoY (2017-2028) & (US$ Million)
    Figure 17. North America Hypersomnia Drug Market Size Market Share by Type (2017-2028)
    Figure 18. North America Hypersomnia Drug Market Size Market Share by Application (2017-2028)
    Figure 19. North America Hypersomnia Drug Market Size Share by Country (2017-2028)
    Figure 20. United States Hypersomnia Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Canada Hypersomnia Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Hypersomnia Drug Market Size YoY (2017-2028) & (US$ Million)
    Figure 23. Europe Hypersomnia Drug Market Size Market Share by Type (2017-2028)
    Figure 24. Europe Hypersomnia Drug Market Size Market Share by Application (2017-2028)
    Figure 25. Europe Hypersomnia Drug Market Size Share by Country (2017-2028)
    Figure 26. Germany Hypersomnia Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. France Hypersomnia Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. U.K. Hypersomnia Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Italy Hypersomnia Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Russia Hypersomnia Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Nordic Countries Hypersomnia Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific Hypersomnia Drug Market Size YoY (2017-2028) & (US$ Million)
    Figure 33. Asia Pacific Hypersomnia Drug Market Size Market Share by Type (2017-2028)
    Figure 34. Asia Pacific Hypersomnia Drug Market Size Market Share by Application (2017-2028)
    Figure 35. Asia Pacific Hypersomnia Drug Market Size Share by Region (2017-2028)
    Figure 36. China Hypersomnia Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Japan Hypersomnia Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. South Korea Hypersomnia Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Southeast Asia Hypersomnia Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. India Hypersomnia Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Australia Hypersomnia Drug Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 42. Latin America Hypersomnia Drug Market Size YoY (2017-2028) & (US$ Million)
    Figure 43. Latin America Hypersomnia Drug Market Size Market Share by Type (2017-2028)
    Figure 44. Latin America Hypersomnia Drug Market Size Market Share by Application (2017-2028)
    Figure 45. Latin America Hypersomnia Drug Market Size Share by Country (2017-2028)
    Figure 46. Mexico Hypersomnia Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Brazil Hypersomnia Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Middle East & Africa Hypersomnia Drug Market Size YoY (2017-2028) & (US$ Million)
    Figure 49. Middle East and Africa Hypersomnia Drug Market Size Market Share by Type (2017-2028)
    Figure 50. Middle East and Africa Hypersomnia Drug Market Size Market Share by Application (2017-2028)
    Figure 51. Middle East and Africa Hypersomnia Drug Market Size Share by Country (2017-2028)
    Figure 52. Turkey Hypersomnia Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. Saudi Arabia Hypersomnia Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. UAE Hypersomnia Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. Teva Revenue Growth Rate in Hypersomnia Drug Business (2017-2022)
    Figure 56. Jazz Pharmaceuticals Revenue Growth Rate in Hypersomnia Drug Business (2017-2022)
    Figure 57. BIOPROJET Revenue Growth Rate in Hypersomnia Drug Business (2017-2022)
    Figure 58. AVADEL PHARMACEUTICALS Revenue Growth Rate in Hypersomnia Drug Business (2017-2022)
    Figure 59. GlaxoSmithKline Revenue Growth Rate in Hypersomnia Drug Business (2017-2022)
    Figure 60. Pfizer Revenue Growth Rate in Hypersomnia Drug Business (2017-2022)
    Figure 61. Theranexus Revenue Growth Rate in Hypersomnia Drug Business (2017-2022)
    Figure 62. Fisher & Paykel Healthcare Revenue Growth Rate in Hypersomnia Drug Business (2017-2022)
    Figure 63. Drive Medical Revenue Growth Rate in Hypersomnia Drug Business (2017-2022)
    Figure 64. Merck Revenue Growth Rate in Hypersomnia Drug Business (2017-2022)
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed